HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Iowa Botanical Center To Study Echinacea, Hypericum Bioactive Constituents

This article was originally published in The Tan Sheet

Executive Summary

A botanical research center at Iowa State University will focus on identifying the bioactive constituents in echinacea and hypericum (St. John's wort)

You may also be interested in...



NIH supports echinacea research

The National Institutes of Health says May 6 it will give $4.4 mil. in continuation funding to an Iowa State University research center dedicated to understanding and improving echinacea and hypericum perforatum (St. John's wort). The Iowa Center for Research on Botanical Dietary Supplements will study the plants' bioavailability for three years, "focusing on cellular, signaling, pathways and receptors," it says. Additionally, researchers will study prunella, known to treat ailments such as inflammatory bowel disease, fever, headache and diarrhea. The center was created in 2002 by NIH's Office of Dietary Supplements (1"The Tan Sheet" July 29, 2002, p. 10)...

Women's Dietary Supplement Use Research Sponsored By FDA, HHS

Researchers at the University of Illinois at Chicago are exploring the patterns of botanical supplement use in 500 menopausal women.

New Botanical Centers To Focus On Polyphenols, Ayurvedic Medicine

Two new NIH-funded dietary supplement research centers have been established at Purdue University and the University of Arizona at Tucson, the National Institutes of Health announced Sept. 20.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS130390

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel